More recently, a prospective study involving nine patients with advanced lung cancer (including four with SqCC, two with ADC, one with adenosquamous carcinoma, one with SCLC, and one with lymphoepithelioma-like carcinoma) reported on the efficacy and safety of 177Lu-FAP-2286 therapy following 68Ga-FAP-2286 PET/CT imaging [121]. This evidence concerns the gene FAP and lung cancer.